We are live on ! Find out more
ECM

Endurant Capital Management Portfolio holdings

AUM $17.4M
1-Year Est. Return 7.38%
This Fund
S&P 500
This Quarter Est. Return
+5.47%
1 Year Est. Return
+7.38%
3 Year Est. Return
+18.38%
5 Year Est. Return
+100.61%
10 Year Est. Return
–
AUM
$299M
AUM Growth
-$9.51M
Cap. Flow
-$30.5M
Cap. Flow %
-10.19%
Top 10 Hldgs %
42.64%
Holding
104
New
18
Increased
30
Reduced
39
Closed
16

Top Buys

Rank Stock Value
1
ABT icon
Abbott
ABT
+$11.4M
2
AGN
Allergan plc
AGN
+$10.5M
3
WMGI
Wright Medical Group Inc
WMGI
+$8.41M
4
SHPG
Shire pic
SHPG
+$6.98M
5
MCK icon
McKesson
MCK
+$4.79M

Top Sells

Rank Stock Value
1
HRC
HILL-ROM HOLDINGS, INC.
HRC
+$8.16M
2
EVHC
Envision Healthcare Holdings Inc
EVHC
+$7.43M
3
ZBH icon
Zimmer Biomet
ZBH
+$7.17M
4
BXLT
BAXALTA INC COM STK (DE)
BXLT
+$7.08M
5
MDT icon
Medtronic
MDT
+$5.39M

Sector Composition

Rank Sector Weight
1 Healthcare 88.92%
2 Financials 3.84%
3 Industrials 1.57%
4 Energy 1.04%
5 Technology 0.1%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AGN
1
DELISTED
Allergan plc
AGN
$16.9M 5.65%
73,100
+45,600
+166% +$10.5M
SHPG
2
DELISTED
Shire pic
SHPG
$14.4M 4.82%
78,396
+38,643
+97% +$6.98M
MNK
3
DELISTED
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
$14.3M 4.77%
234,729
+3,500
+2% +$214K
EHC icon
4
Encompass Health
EHC
$11B
$14.2M 4.76%
460,707
+909
+0.2% +$28.4K
MCK icon
5
McKesson
MCK
$100B
$13.2M 4.41%
70,638
+27,291
+63% +$4.79M
ABT icon
6
Abbott
ABT
$183B
$12.1M 4.04%
307,502
+287,418
+1,431% +$11.4M
TEVA icon
7
Teva Pharmaceuticals
TEVA
$40.8B
$11.6M 3.87%
230,533
-94,300
-29% -$5.02M
AET
8
DELISTED
Aetna Inc
AET
$11.5M 3.84%
94,115
-1,100
-1% -$126K
WMGI
9
DELISTED
Wright Medical Group Inc
WMGI
$9.94M 3.32%
572,028
+458,400
+403% +$8.41M
STJ
10
DELISTED
St Jude Medical
STJ
$9.46M 3.16%
121,282
-24,600
-17% -$1.75M
BSX icon
11
Boston Scientific
BSX
$69.5B
$8.58M 2.87%
366,998
-159,700
-30% -$3.45M
TMO icon
12
Thermo Fisher Scientific
TMO
$213B
$7.64M 2.55%
51,686
-1,800
-3% -$266K
CNC icon
13
Centene
CNC
$30.7B
$7.28M 2.43%
204,076
+52,400
+35% +$1.65M
UNH icon
14
UnitedHealth
UNH
$376B
$7.15M 2.39%
50,606
-18,900
-27% -$2.52M
WBA
15
DELISTED
Walgreens Boots Alliance
WBA
$6.52M 2.18%
78,314
-28,200
-26% -$2.28M
LH icon
16
Labcorp
LH
$25B
$6.18M 2.06%
55,188
+8,148
+17% +$877K
UHS icon
17
Universal Health Services
UHS
$10.2B
$5.89M 1.97%
43,907
+2,000
+5% +$264K
HOLX
18
DELISTED
Hologic
HOLX
$5.82M 1.95%
168,208
+106,508
+173% +$3.69M
SYK icon
19
Stryker
SYK
$125B
$5.33M 1.78%
44,465
-23,895
-35% -$2.67M
BIIB icon
20
Biogen
BIIB
$30B
$4.96M 1.66%
20,532
-12,200
-37% -$3.22M
BDX icon
21
Becton Dickinson
BDX
$45.6B
$4.96M 1.66%
29,990
-16,093
-35% -$2.57M
SPNC
22
DELISTED
Spectranetics Corp
SPNC
$4.56M 1.52%
243,626
-189,100
-44% -$3.33M
DVA icon
23
DaVita
DVA
$15.4B
$4.17M 1.39%
53,889
+13,100
+32% +$990K
A icon
24
Agilent Technologies
A
$39.1B
$4.01M 1.34%
90,485
-400
-0.4% -$17.3K
AMGN icon
25
Amgen
AMGN
$208B
$4M 1.34%
26,300
+20,700
+370% +$3.22M
1
2 3 4 5

Similar funds

VAFP
Vahanian & Associates Financial Planning Saratoga Springs, New York $25.3M AUM 39.42% 1-Year Est. Return
CA
Corriente Advisors Fort Worth, Texas $9.53M AUM 805.26% 1-Year Est. Return
SCM
Somerset Capital Management London, United Kingdom $8.12M AUM 21.3% 1-Year Est. Return
FWM
Fiat Wealth Management Wayzata, Minnesota $7.9M AUM
TOPU
Trustees of Princeton University Princeton, New Jersey $7.77M AUM
CCMU
Cheyne Capital Management (UK) London, United Kingdom $27.9M AUM 36.14% 1-Year Est. Return
TGI
TRV GP III Boston, Massachusetts $6.14M AUM 45.44% 1-Year Est. Return
HSCU
Half Sky Capital (UK) London, United Kingdom $30.5M AUM 67.32% 1-Year Est. Return

Endurant Capital Management's Q2 2016 Portfolio in Review

As of Q2 2016, Endurant Capital Management held 104 positions worth $299M, down 3.1% from $309M the previous quarter. Its ten largest holdings account for 43% of the portfolio.

Endurant Capital Management withdrew a net $30.5M in Q2 2016, closing 16 positions and reducing 39 holdings. Its most notable exit was BAXALTA INC COM STK (DE), an estimated $7.08M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 89% of assets, up from 84% a quarter earlier, followed by Financials and Industrials.

Against the trend, Endurant Capital Management opened a new position in Cencora worth $3.85M.

  • Endurant Capital Management's largest Q2 2016 buy was Cencora: 48,600 shares worth $3.85M.
  • Endurant Capital Management added most to Abbott in Q2 2016, an estimated $11.4M increase.
  • Endurant Capital Management's biggest Q2 2016 reduction was HILL-ROM HOLDINGS, INC., cutting an estimated $8.16M.
  • Endurant Capital Management fully exited BAXALTA INC COM STK (DE) in Q2 2016, selling an estimated $7.08M.
  • Endurant Capital Management's ten largest holdings make up 43% of its $299M portfolio in Q2 2016.
  • Endurant Capital Management opened 18 new positions and closed 16 in Q2 2016.
  • Endurant Capital Management's portfolio value fell 3.1% quarter-over-quarter to $299M.

Based on Endurant Capital Management's 13F filing for Q2 2016, filed 15 Aug 2016.